James Kahn, MD

Email James
(415) 476-4082 x408

3333 California Street
San Francisco, CA 94118

Visit CTSI Profile

  • Professor, School of Medicine
  • Mentoring Program Director
  • CNICS Executive Committee Co-Chair

Displaying 1 - 141 of 141

  1. Cepeda JA, Burgos JL, Kahn JG, Padilla R, Meza Martinez PE, Segovia LA, Gaines T, Abramovitz D, Rangel G, Magis-Rodriguez C, Vickerman P, Strathdee SA, Martin NK. Evaluating the impact of global fund withdrawal on needle and syringe provision, cost and use among people who inject drugs in Tijuana, Mexico: a costing analysis. BMJ Open. 2019 Jan 29; 9(1):e026298. View on Pubmed
  2. Mustafa Diab M, Shearer DW, Kahn JG, Wu HH, Lau B, Morshed S, Chokotho L. The Cost of Intramedullary Nailing Versus Skeletal Traction for Treatment of Femoral Shaft Fractures in Malawi: A Prospective Economic Analysis. World J Surg. 2019 01; 43(1):87-95. View on Pubmed
  3. Chomsky-Higgins K, Kahn JG. Interventions and Innovation to Prevent Surgical Site Infection in Colorectal Surgery: A Cost-Effectiveness Analysis. J Surg Res. 2019 Mar; 235:373-382. View on Pubmed
  4. Matuoka JY, Kahn JG, Secoli SR. Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review. Eur J Health Econ. 2018 Oct 31. View on Pubmed
  5. Parriott A, Malekinejad M, Miller AP, Horvath H, Marks SM, Kahn JG. Yield of testing and treatment for tuberculosis among foreign-born persons during contact investigations in the United States: A semi-systematic review. PLoS One. 2018; 13(7):e0200485. View on Pubmed
  6. Chamie G, Schaffer EM, Ndyabakira A, Emperador DM, Kwarisiima D, Camlin CS, Havlir DV, Kahn JG, Kamya MR, Thirumurthy H. Comparative effectiveness of novel nonmonetary incentives to promote HIV testing. AIDS. 2018 Jul 17; 32(11):1443-1451. View on Pubmed
  7. Herzel BJ, Samuel SP, Bulfone TC, Raj CS, Lewin M, Kahn JG. Snakebite: An Exploratory Cost-Effectiveness Analysis of Adjunct Treatment Strategies. Am J Trop Med Hyg. 2018 Aug; 99(2):404-412. View on Pubmed
  8. Shen J, Olwanda E, Kahn JG, Huchko MJ. Cost of HPV screening at community health campaigns (CHCs) and health clinics in rural Kenya. BMC Health Serv Res. 2018 05 25; 18(1):378. View on Pubmed
  9. Burgos JL, Cepeda JA, Kahn JG, Mittal ML, Meza E, Lazos RRP, Vargas PC, Vickerman P, Strathdee SA, Martin NK. Cost of provision of opioid substitution therapy provision in Tijuana, Mexico. Harm Reduct J. 2018 05 23; 15(1):28. View on Pubmed
  10. Mirzazadeh A, Biggs MA, Viitanen A, Horvath H, Wang LY, Dunville R, Barrios LC, Kahn JG, Marseille E. Do School-Based Programs Prevent HIV and Other Sexually Transmitted Infections in Adolescents? A Systematic Review and Meta-analysis. Prev Sci. 2018 May; 19(4):490-506. View on Pubmed
  11. Marseille E, Mirzazadeh A, Biggs MA, P Miller A, Horvath H, Lightfoot M, Malekinejad M, Kahn JG. Effectiveness of School-Based Teen Pregnancy Prevention Programs in the USA: a Systematic Review and Meta-Analysis. Prev Sci. 2018 May; 19(4):468-489. View on Pubmed
  12. Parriott A, Malekinejad M, Miller AP, Marks SM, Horvath H, Kahn JG. Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis. BMC Public Health. 2018 Apr 12; 18(1):485. View on Pubmed
  13. Olwanda E, Shen J, Kahn JG, Bryant-Comstock K, Huchko MJ. Comparison of patient flow and provider efficiency of two delivery strategies for HPV-based cervical cancer screening in Western Kenya: a time and motion study. Glob Health Action. 2018; 11(1):1451455. View on Pubmed
  14. Huchko MJ, Kahn JG, Smith JS, Hiatt RA, Cohen CR, Bukusi E. Study protocol for a cluster-randomized trial to compare human papillomavirus based cervical cancer screening in community-health campaigns versus health facilities in western Kenya. BMC Cancer. 2017 Dec 06; 17(1):826. View on Pubmed
  15. Semitala FC, Camlin CS, Wallenta J, Kampiire L, Katuramu R, Amanyire G, Namusobya J, Chang W, Kahn JG, Charlebois ED, Havlir DV, Kamya MR, Geng EH. Understanding uptake of an intervention to accelerate antiretroviral therapy initiation in Uganda via qualitative inquiry. J Int AIDS Soc. 2017 12; 20(4). View on Pubmed
  16. Chomsky-Higgins K, Seib C, Rochefort H, Gosnell J, Shen WT, Kahn JG, Duh QY, Suh I. Less is more: cost-effectiveness analysis of surveillance strategies for small, nonfunctional, radiographically benign adrenal incidentalomas. Surgery. 2018 01; 163(1):197-204. View on Pubmed
  17. Malekinejad M, Parriott A, Viitanen AP, Horvath H, Marks SM, Kahn JG. Yield of community-based tuberculosis targeted testing and treatment in foreign-born populations in the United States: A systematic review. PLoS One. 2017; 12(8):e0180707. View on Pubmed
  18. Malekinejad M, Parriott A, Blodgett JC, Horvath H, Shrestha RK, Hutchinson AB, Volberding P, Kahn JG. Effectiveness of community-based condom distribution interventions to prevent HIV in the United States: A systematic review and meta-analysis. PLoS One. 2017; 12(8):e0180718. View on Pubmed
  19. Vreman RA, Goodell AJ, Rodriguez LA, Porco TC, Lustig RH, Kahn JG. Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model. BMJ Open. 2017 Aug 03; 7(8):e013543. View on Pubmed
  20. Kortz TB, Herzel B, Marseille E, Kahn JG. Bubble continuous positive airway pressure in the treatment of severe paediatric pneumonia in Malawi: a cost-effectiveness analysis. BMJ Open. 2017 Jul 10; 7(7):e015344. View on Pubmed
  21. Schillinger D, Kahn JG. Mobilizing for a war on the home front against sugar-related morbidity and mortality. Isr J Health Policy Res. 2017; 6:32. View on Pubmed
  22. Salazar J, Saxena V, Kahn JG, Roberts JP, Mehta N, Volk M, Lai JC. Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2017 05; 101(5):1001-1008. View on Pubmed
  23. Chang W, Chamie G, Mwai D, Clark TD, Thirumurthy H, Charlebois ED, Petersen M, Kabami J, Ssemmondo E, Kadede K, Kwarisiima D, Sang N, Bukusi EA, Cohen CR, Kamya M, Havlir DV, Kahn JG. Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa. J Acquir Immune Defic Syndr. 2016 Nov 01; 73(3):e39-e45. View on Pubmed
  24. Zygourakis CC, Imber BS, Chen R, Han SJ, Blevins L, Molinaro A, Kahn JG, Aghi MK. Cost-Effectiveness Analysis of Surgical versus Medical Treatment of Prolactinomas. J Neurol Surg B Skull Base. 2017 Apr; 78(2):125-131. View on Pubmed
  25. Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, Charlebois E, Camlin C, Kahn J, Chang W, Glidden D, Kamya M, Havlir D, Geng E. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Lancet HIV. 2016 11; 3(11):e539-e548. View on Pubmed
  26. Goodell AJ, Kahn JG, Ndeki SS, Kaale E, Kaaya EE, Macfarlane SB. Modeling solutions to Tanzania's physician workforce challenge. Glob Health Action. 2016; 9:31597. View on Pubmed
  27. Marseille E, Kahn JG. A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact. PLoS Med. 2016 05; 13(5):e1002031. View on Pubmed
  28. Burgos JL, Patterson TL, Graff-Zivin JS, Kahn JG, Rangel MG, Lozada MR, Staines H, Strathdee SA. Cost-Effectiveness of Combined Sexual and Injection Risk Reduction Interventions among Female Sex Workers Who Inject Drugs in Two Very Distinct Mexican Border Cities. PLoS One. 2016; 11(2):e0147719. View on Pubmed
  29. Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med. 2016 Jan; 176(1):65-73. View on Pubmed
  30. Jain V, Chang W, Byonanebye DM, Owaraganise A, Twinomuhwezi E, Amanyire G, Black D, Marseille E, Kamya MR, Havlir DV, Kahn JG. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda. PLoS One. 2015; 10(12):e0143433. View on Pubmed
  31. Kwek SS, Kahn J, Greaney SK, Lewis J, Cha E, Zhang L, Weber RW, Leonard L, Markovic SN, Fong L, Spitler LE. GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses. Oncoimmunology. 2016 Apr; 5(4):e1101204. View on Pubmed
  32. Curl PK, Kahn JG, Ordovas KG, Elicker BM, Naeger DM. Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening. AJR Am J Roentgenol. 2015 Aug; 205(2):344-7. View on Pubmed
  33. Patel MI, Bhattacharya J, Asch SM, Kahn J. Acceptance of Advance Directives and Palliative Care Referral for Veterans With Advanced Cancer: A Retrospective Analysis. Am J Hosp Palliat Care. 2016 Sep; 33(8):742-7. View on Pubmed
  34. Kahn JG, Hofmann P. Research ethics and health care reform. Science. 2015 Jun 19; 348(6241):1325-6. View on Pubmed
  35. Verguet S, Kahn JG, Marseille E, Jiwani A, Kern E, Walson JL. Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya? Glob Health Action. 2015; 8:27695. View on Pubmed
  36. Curl P, Vujic I, van 't Veer LJ, Ortiz-Urda S, Kahn JG. Correction: Cost-Effectiveness Of Treatment Strategies for BRAF-Mutated Metastatic Melanoma. PLoS One. 2015; 10(4):e0126988. View on Pubmed
  37. Chen IT, Aung T, Thant HN, Sudhinaraset M, Kahn JG. Cost-effectiveness analysis of malaria rapid diagnostic test incentive schemes for informal private healthcare providers in Myanmar. Malar J. 2015 Feb 05; 14:55. View on Pubmed
  38. Juillard C, Smith R, Anaya N, Garcia A, Kahn JG, Dicker RA. Saving lives and saving money: hospital-based violence intervention is cost-effective. J Trauma Acute Care Surg. 2015 Feb; 78(2):252-7; discussion 257-8. View on Pubmed
  39. Downing J, El Ayadi A, Miller S, Butrick E, Mkumba G, Magwali T, Kaseba-Sata C, Kahn JG. Cost-effectiveness of the non-pneumatic anti-shock garment (NASG): evidence from a cluster randomized controlled trial in Zambia and Zimbabwe. BMC Health Serv Res. 2015 Jan 28; 15:37. View on Pubmed
  40. Mirzazadeh A, Malekinejad M, Kahn JG. Relative risk reduction is useful metric to standardize effect size for public heath interventions for translational research. J Clin Epidemiol. 2015 Mar; 68(3):317-23. View on Pubmed
  41. Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015 Feb 01; 93(2):118-24. View on Pubmed
  42. Jiwani A, Himmelstein D, Woolhandler S, Kahn JG. Billing and insurance-related administrative costs in United States' health care: synthesis of micro-costing evidence. BMC Health Serv Res. 2014 Nov 13; 14:556. View on Pubmed
  43. Zygourakis CC, Kahn JG. Cost-effectiveness research in neurosurgery. Neurosurg Clin N Am. 2015 Apr; 26(2):189-96, viii. View on Pubmed
  44. Zygourakis CC, Oh T, Sun MZ, Barani I, Kahn JG, Parsa AT. Surgery is cost-effective treatment for young patients with vestibular schwannomas: decision tree modeling of surgery, radiation, and observation. Neurosurg Focus. 2014 Nov; 37(5):E8. View on Pubmed
  45. Curl P, Vujic I, van 't Veer LJ, Ortiz-Urda S, Kahn JG. Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma. PLoS One. 2014; 9(9):e107255. View on Pubmed
  46. Marseille E, Kahn JG. Avahan and the cost-effectiveness of "prevention as prevention". Lancet Glob Health. 2014 Sep; 2(9):e493-e494. View on Pubmed
  47. Weile LK, Kahn JG, Marseille E, Jensen DM, Damm P, Lohse N. Global cost-effectiveness of GDM screening and management: current knowledge and future needs. Best Pract Res Clin Obstet Gynaecol. 2015 Feb; 29(2):206-24. View on Pubmed
  48. Lima VD, Thirumurthy H, Kahn JG, Saavedra J, Cárceres CF, Whiteside A. Modeling scenarios for the end of AIDS. Clin Infect Dis. 2014 Jul; 59 Suppl 1:S16-20. View on Pubmed
  49. Marseille E, Jiwani A, Raut A, Verguet S, Walson J, Kahn JG. Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries. BMJ Open. 2014 Jun 26; 4(6):e003987. View on Pubmed
  50. Jiwani A, Matheson A, Kahn JG, Raut A, Verguet S, Marseille E, Walson J. Integrated disease prevention campaigns: assessing country opportunity for implementation via an index approach. BMJ Open. 2014 Mar 19; 4(3):e004308. View on Pubmed
  51. Kahn JG, Jiwani A, Gomez GB, Hawkes SJ, Chesson HW, Broutet N, Kamb ML, Newman LM. The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model. PLoS One. 2014; 9(1):e87510. View on Pubmed
  52. Marseille E, Kahn JG, Beatty S, Jared M, Perchal P. Adult male circumcision in Nyanza, Kenya at scale: the cost and efficiency of alternative service delivery modes. BMC Health Serv Res. 2014 Jan 23; 14:31. View on Pubmed
  53. Kahn JG, Marseille EA. Capsule commentary on Long and Stavert, portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis. J Gen Intern Med. 2013 Oct; 28(10):1350. View on Pubmed
  54. Yanik EL, Napravnik S, Ryscavage P, Eron JJ, Koletar SL, Moore RD, Zinski A, Cole SR, Hunt P, Crane HM, Kahn J, Mathews WC, Mayer KH, Taiwo BO. Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010. J Acquir Immune Defic Syndr. 2013 Jun 01; 63(2):216-20. View on Pubmed
  55. Kahn JG, Marseille EA. Viral load monitoring for antiretroviral therapy in resource-poor settings: an evolving role. AIDS. 2013 Jun 01; 27(9):1509-11. View on Pubmed
  56. Kern E, Verguet S, Yuhas K, Odhiambo FH, Kahn JG, Walson J. Provision of bednets and water filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan multisite study. Trop Med Int Health. 2013 Aug; 18(8):916-24. View on Pubmed
  57. Sutherland T, Downing J, Miller S, Bishai DM, Butrick E, Fathalla MM, Mourad-Youssif M, Ojengbede O, Nsima D, Kahn JG. Use of the non-pneumatic anti-shock garment (NASG) for life-threatening obstetric hemorrhage: a cost-effectiveness analysis in Egypt and Nigeria. PLoS One. 2013; 8(4):e62282. View on Pubmed
  58. Audureau E, Kahn JG, Besson MH, Saba J, Ladner J. Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance. BMC Public Health. 2013 Apr 01; 13:286. View on Pubmed
  59. Marseille E, Lohse N, Jiwani A, Hod M, Seshiah V, Yajnik CS, Arora GP, Balaji V, Henriksen O, Lieberman N, Chen R, Damm P, Metzger BE, Kahn JG. The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med. 2013 May; 26(8):802-10. View on Pubmed
  60. Velayos FS, Kahn JG, Sandborn WJ, Feagan BG. A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab. Clin Gastroenterol Hepatol. 2013 Jun; 11(6):654-66. View on Pubmed
  61. Marseille E, Giganti MJ, Mwango A, Chisembele-Taylor A, Mulenga L, Over M, Kahn JG, Stringer JS. Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia. PLoS One. 2012; 7(12):e51993. View on Pubmed
  62. Abeyasinghe RR, Galappaththy GN, Smith Gueye C, Kahn JG, Feachem RG. Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One. 2012; 7(8):e43162. View on Pubmed
  63. Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, Sabin ML, Makhlouf-Obermeyer C, De Filippo Mack C, Williams P, Jones L, Smyth C, Kutch KA, Ying-Ru L, Vitoria M, Souteyrand Y, Crowley S, Korenromp EL, Williams BG. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One. 2012; 7(2):e30216. View on Pubmed
  64. Kahn JG, Muraguri N, Harris B, Lugada E, Clasen T, Grabowsky M, Mermin J, Shariff S. Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness. PLoS One. 2012; 7(2):e31316. View on Pubmed
  65. Kahn JG, Harris B, Mermin JH, Clasen T, Lugada E, Grabowksy M, Vestergaard Frandsen M, Garg N. Cost of community integrated prevention campaign for malaria, HIV, and diarrhea in rural Kenya. BMC Health Serv Res. 2011 Dec 21; 11:346. View on Pubmed
  66. Marseille EA, Kevany S, Ahmed I, Feleke G, Graham B, Heller T, Kahn JG, Reyes M. Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study. Cost Eff Resour Alloc. 2011 Dec 20; 9:18. View on Pubmed
  67. Kahn JG, Marseille E, Moore D, Bunnell R, Were W, Degerman R, Tappero JW, Ekwaru P, Kaharuza F, Mermin J. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011 Nov 09; 343:d6884. View on Pubmed
  68. Lohse N, Marseille E, Kahn JG. Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus. Int J Gynaecol Obstet. 2011 Nov; 115 Suppl 1:S20-5. View on Pubmed
  69. Bozic KJ, Chiu V, Slover JD, Immerman I, Kahn JG. Patient preferences and willingness to pay for arthroplasty surgery in patients with osteoarthritis of the hip. J Arthroplasty. 2012 Apr; 27(4):503-506.e2. View on Pubmed
  70. Tatarsky A, Aboobakar S, Cohen JM, Gopee N, Bheecarry A, Moonasar D, Phillips AA, Kahn JG, Moonen B, Smith DL, Sabot O. Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PLoS One. 2011; 6(9):e23832. View on Pubmed
  71. Kahn JG, Marseille EA, Bennett R, Williams BG, Granich R. Cost-effectiveness of antiretroviral therapy for prevention. Curr HIV Res. 2011 Sep; 9(6):405-15. View on Pubmed
  72. Jones L, Akugizibwe P, Clayton M, Amon JJ, Sabin ML, Bennett R, Stegling C, Baggaley R, Kahn JG, Holmes CB, Garg N, Obermeyer CM, Mack CD, Williams P, Smyth C, Vitoria M, Crowley S, Williams B, McClure C, Granich R, Hirnschall G. Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting. Curr HIV Res. 2011 Sep; 9(6):416-28. View on Pubmed
  73. Granich R, Lo YR, Suthar AB, Vitoria M, Baggaley R, Obermeyer CM, McClure C, Souteyrand Y, Perriens J, Kahn JG, Bennett R, Smyth C, Williams B, Montaner J, Hirnschall G. Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis. Curr HIV Res. 2011 Sep; 9(6):355-66. View on Pubmed
  74. Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med. 2012 Jun; 25(6):600-10. View on Pubmed
  75. De Ver Dye T, Apondi R, Lugada E, Kahn JG, Sandiford-Day MA, Dasbanerjee T. A qualitative assessment of beliefs, attitudes, and behaviors related to diarrhea and water filtration in rural Kenya. Am J Public Health. 2011 Aug; 101(8):1515-20. View on Pubmed
  76. Bozic KJ, Chiu VW, Slover JD, Immerman I, Kahn JG. Health state utility in patients with osteoarthritis of the hip and total hip arthroplasty. J Arthroplasty. 2011 Sep; 26(6 Suppl):129-132.e1-2. View on Pubmed
  77. Dye TD, Apondi R, Lugada ES, Kahn JG, Smith J, Othoro C. "Before we used to get sick all the time": perceptions of malaria and use of long-lasting insecticide-treated bed nets (LLINs) in a rural Kenyan community. Malar J. 2010 Nov 30; 9:345. View on Pubmed
  78. Sabot O, Cohen JM, Hsiang MS, Kahn JG, Basu S, Tang L, Zheng B, Gao Q, Zou L, Tatarsky A, Aboobakar S, Usas J, Barrett S, Cohen JL, Jamison DT, Feachem RG. Costs and financial feasibility of malaria elimination. Lancet. 2010 Nov 06; 376(9752):1604-15. View on Pubmed
  79. Lugada E, Millar D, Haskew J, Grabowsky M, Garg N, Vestergaard M, Kahn JG, Khan JG, Kahn J, Muraguri N, Mermin J. Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One. 2010 Aug 26; 5(8):e12435. View on Pubmed
  80. Granich R, Crowley S, Vitoria M, Smyth C, Kahn JG, Bennett R, Lo YR, Souteyrand Y, Williams B. Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS. 2010 Jul; 5(4):298-304. View on Pubmed
  81. Kahn JG, Yang JS, Kahn JS. 'Mobile' health needs and opportunities in developing countries. Health Aff (Millwood). 2010 Feb; 29(2):252-8. View on Pubmed
  82. Doyle SM, Kahn JG, Hosang N, Carroll PR. The impact of male circumcision on HIV transmission. J Urol. 2010 Jan; 183(1):21-6. View on Pubmed
  83. Breban R, Napravnik S, Kahn J, Blower S. Quantifying the treatment efficacy of reverse transcriptase inhibitors: new analyses of clinical data based on within-host modeling. BMC Public Health. 2009 Nov 18; 9 Suppl 1:S11. View on Pubmed
  84. Burgos JL, Kahn JG, Strathdee SA, Valencia-Mendoza A, Bautista-Arredondo S, Laniado-Laborin R, Castañeda R, Deiss R, Garfein RS. Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico. Int J Tuberc Lung Dis. 2009 Aug; 13(8):962-8. View on Pubmed
  85. Sakowski JA, Kahn JG, Kronick RG, Newman JM, Luft HS. Peering into the black box: billing and insurance activities in a medical group. Health Aff (Millwood). 2009 Jul-Aug; 28(4):w544-54. View on Pubmed
  86. Marseille E, Kahn JG, Pitter C, Bunnell R, Epalatai W, Jawe E, Were W, Mermin J. The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Appl Health Econ Health Policy. 2009; 7(4):229-43. View on Pubmed
  87. Auvert B, Marseille E, Korenromp EL, Lloyd-Smith J, Sitta R, Taljaard D, Pretorius C, Williams B, Kahn JG. Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS One. 2008 Aug 06; 3(8):e2679. View on Pubmed
  88. Dandona L, Kumar SP, Ramesh Y, Rao MC, Kumar AA, Marseille E, Kahn JG, Dandona R. Changing cost of HIV interventions in the context of scaling-up in India. AIDS. 2008 Jul; 22 Suppl 1:S43-9. View on Pubmed
  89. Kürzinger ML, Pagnier J, Kahn JG, Hampshire R, Wakabi T, Dye TD. Education status among orphans and non-orphans in communities affected by AIDS in Tanzania and Burkina Faso. AIDS Care. 2008 Jul; 20(6):726-32. View on Pubmed
  90. Potts M, Halperin DT, Kirby D, Swidler A, Marseille E, Klausner JD, Hearst N, Wamai RG, Kahn JG, Walsh J. Public health. Reassessing HIV prevention. Science. 2008 May 09; 320(5877):749-50. View on Pubmed
  91. Kahn J, Des Jarlais CD, Dobkin L, Barrs SF, Greenblatt RM. Mentoring the next generation of HIV prevention researchers: a model mentoring program at the University of California San Francisco and Gladstone Institute of Immunology and Virology Center for AIDS research. J Acquir Immune Defic Syndr. 2008 Mar 01; 47 Suppl 1:S5-9. View on Pubmed
  92. Dandona L, Kumar SG, Ramesh YK, Rao MC, Marseille E, Kahn JG, Dandona R. Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India. BMC Health Serv Res. 2008 Jan 31; 8:26. View on Pubmed
  93. Marseille E, Dandona L, Marshall N, Gaist P, Bautista-Arredondo S, Rollins B, Bertozzi SM, Coovadia J, Saba J, Lioznov D, Du Plessis JA, Krupitsky E, Stanley N, Over M, Peryshkina A, Kumar SG, Muyingo S, Pitter C, Lundberg M, Kahn JG. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res. 2007 Jul 12; 7:108. View on Pubmed
  94. Pitter C, Kahn JG, Marseille E, Lule JR, McFarland DA, Ekwaru JP, Bunnell R, Coutinho A, Mermin J. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. J Acquir Immune Defic Syndr. 2007 Mar 01; 44(3):336-43. View on Pubmed
  95. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 2006 Dec; 3(12):e517. View on Pubmed
  96. Gardner A, Kahn JG. Increasing access to care for the uninsured: considering the options in California counties. J Health Care Poor Underserved. 2006 Nov; 17(4):830-50. View on Pubmed
  97. Wilson DP, Kahn J, Blower SM. Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: the effect of the urban-rural divide. Proc Natl Acad Sci U S A. 2006 Sep 19; 103(38):14228-33. View on Pubmed
  98. Shrestha RK, Marseille E, Kahn JG, Lule JR, Pitter C, Blandford JM, Bunnell R, Coutinho A, Kizito F, Quick R, Mermin J. Cost-effectiveness of home-based chlorination and safe water storage in reducing diarrhea among HIV-affected households in rural Uganda. Am J Trop Med Hyg. 2006 May; 74(5):884-90. View on Pubmed
  99. Marseille E, Saba J, Muyingo S, Kahn JG. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda. AIDS. 2006 Apr 04; 20(6):907-14. View on Pubmed
  100. Bozic KJ, Morshed S, Silverstein MD, Rubash HE, Kahn JG. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am. 2006 Apr; 88(4):706-14. View on Pubmed
  101. Ikard K, Janney J, Hsu LC, Isenberg DJ, Scalco MB, Schwarcz S, Beer L, Wendell DA, Franks PE, Kahn JG. Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Educ Prev. 2005 Dec; 17(6 Suppl B):26-38. View on Pubmed
  102. McConnel CE, Stanley N, du Plessis JA, Pitter CS, Abdulla F, Coovadia HM, Marseille E, Kahn JG. The cost of a rapid-test VCT clinic in South Africa. S Afr Med J. 2005 Dec; 95(12):968-71. View on Pubmed
  103. Dandona L, Sisodia P, Prasad TL, Marseille E, Chalapathi Rao M, Kumar AA, Kumar SG, Ramesh YK, Over M, Someshwar M, Kahn JG. Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India. BMC Health Serv Res. 2005 Nov 05; 5:69. View on Pubmed
  104. Kahn JG, Kronick R, Kreger M, Gans DN. The cost of health insurance administration in California: estimates for insurers, physicians, and hospitals. Health Aff (Millwood). 2005 Nov-Dec; 24(6):1629-39. View on Pubmed
  105. Dandona L, Sisodia P, Kumar SG, Ramesh YK, Kumar AA, Rao MC, Marseille E, Someshwar M, Marshall N, Kahn JG. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency. BMC Public Health. 2005 Sep 24; 5:98. View on Pubmed
  106. Buchmueller TC, Grumbach K, Kronick R, Kahn JG. The effect of health insurance on medical care utilization and implications for insurance expansion: a review of the literature. Med Care Res Rev. 2005 Feb; 62(1):3-30. View on Pubmed
  107. Blower S, Bodine E, Kahn J, McFarland W. The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS. 2005 Jan 03; 19(1):1-14. View on Pubmed
  108. Marseille E, Dandona L, Saba J, McConnel C, Rollins B, Gaist P, Lundberg M, Over M, Bertozzi S, Kahn JG. Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project. Health Serv Res. 2004 Dec; 39(6 Pt 2):1993-2012. View on Pubmed
  109. Wilson AR, Kahn JG. Preventing HIV in injection drug users: choosing the best mix of interventions for the population. J Urban Health. 2003 Sep; 80(3):465-81. View on Pubmed
  110. Jacobson MA, Liu L, Khayam-Bashi H, Deeks SG, Hecht FM, Kahn J. Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy. AIDS. 2003 Apr 11; 17(6):917-9. View on Pubmed
  111. Bitton A, Kahn JG. MSJAMA: Government share of health care expenditures. JAMA. 2003 Mar 05; 289(9):1165. View on Pubmed
  112. Kahn J. Preventing hepatitis A and hepatitis B virus infections among men who have sex with men. Clin Infect Dis. 2002 Dec 01; 35(11):1382-7. View on Pubmed
  113. Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr. 2002 Oct 01; 31(2):237-42. View on Pubmed
  114. Marseille E, Hofmann PB, Kahn JG. HIV prevention before HAART in sub-Saharan Africa. Lancet. 2002 May 25; 359(9320):1851-6. View on Pubmed
  115. Kahn JG, Zhang X, Cross LT, Palacio H, Birkhead GS, Morin SF. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S. Public Health Rep. 2002 May-Jun; 117(3):252-62; discussion 231-2. View on Pubmed
  116. Palacio H, Kahn JG, Richards TA, Morin SF. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep. 2002 May-Jun; 117(3):233-51; discussion 231-2. View on Pubmed
  117. Morin SF, Sengupta S, Cozen M, Richards TA, Shriver MD, Palacio H, Kahn JG. Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies. Public Health Rep. 2002 May-Jun; 117(3):263-72; discussion 231-2. View on Pubmed
  118. Kahn JG, Marseille E. A saga in international HIV policy modeling: preventing mother-to-child HIV transmission. J Policy Anal Manage. 2002; 21(3):499-505. View on Pubmed
  119. Eichner J, Kahn JG. Coordination of health coverage for Medicare enrollees: living with HIV/AIDS in California. Medicare Brief. 2001 Aug; (8):1-10. View on Pubmed
  120. Kahn JG. Expenditures for the care of patients with HIV. N Engl J Med. 2001 Jun 21; 344(25):1948-9. View on Pubmed
  121. Johnston SC, Gress DR, Kahn JG. Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology. 1999 Jun 10; 52(9):1806-15. View on Pubmed
  122. Kahn JG, Pinkerton SD, Paltiel AD. Postexposure prophylaxis following HIV exposure. JAMA. 1999 Apr 14; 281(14):1269-70. View on Pubmed
  123. Kahn JG, Brindis CD, Glei DA. Pregnancies averted among U.S. teenagers by the use of contraceptives. Fam Plann Perspect. 1999 Jan-Feb; 31(1):29-34. View on Pubmed
  124. Kahn JG, Gurvey J, Pollack LM, Binson D, Catania JA. How many HIV infections cross the bisexual bridge? An estimate from the United States. AIDS. 1997 Jul; 11(8):1031-7. View on Pubmed
  125. Marx R, Franks PE, Kahn JG, Sanstad KC, Werdegar D. HIV education and prevention in California: problems and progress. HIV Education and Prevention Evaluation Team. AIDS Public Policy J. 1997; 12(1):31-45. View on Pubmed
  126. Kahn JG, Sanstad KC. The role of cost-effectiveness analysis in assessing HIV-prevention interventions. AIDS Public Policy J. 1997; 12(1):21-30. View on Pubmed
  127. Grover CM, Kuppermann M, Kahn JG, Washington AE. Concurrent hysterectomy at bilateral salpingo-oophorectomy: benefits, risks, and costs. Obstet Gynecol. 1996 Dec; 88(6):907-13. View on Pubmed
  128. Lurie P, Avins AL, Phillips KA, Kahn JG, Lowe RA, Ciccarone D. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection. JAMA. 1994 Dec 21; 272(23):1832-8. View on Pubmed
  129. Walker CK, Kahn JG, Washington AE, Peterson HB, Sweet RL. Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy. J Infect Dis. 1993 Oct; 168(4):969-78. View on Pubmed
  130. Lurie P, Lowe RA, Avins AL, Phillips KA, Kahn JG, Franks PE, Ciccarone DH. Undiagnosed HIV infection in acute care hospitals. N Engl J Med. 1992 Dec 17; 327(25):1815-6. View on Pubmed
  131. Kahn JG, Lurie P, Grumbach K. Consumer choices and the American health care system. JAMA. 1992 Sep 09; 268(10):1265-6. View on Pubmed
  132. Lurie P, Kahn JG, Wolfe SM. Regulation of benzodiazepine prescription. JAMA. 1992 Jul 22-29; 268(4):472-3; author reply 473-4. View on Pubmed
  133. Peterson HB, Walker CK, Kahn JG, Washington AE, Eschenbach DA, Faro S. Pelvic inflammatory disease. Key treatment issues and options. JAMA. 1991 Nov 13; 266(18):2605-11. View on Pubmed
  134. Marx R, Aral SO, Rolfs RT, Sterk CE, Kahn JG. Crack, sex, and STD. Sex Transm Dis. 1991 Apr-Jun; 18(2):92-101. View on Pubmed
  135. Walker CK, Kahn JG, Washington AE, Peterson HB, Sweet RL. Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy. J Infect Dis. 1993 Oct; 168(4):969-78. View on Pubmed
  136. Lurie P, Lowe RA, Avins AL, Phillips KA, Kahn JG, Franks PE, Ciccarone DH. Undiagnosed HIV infection in acute care hospitals. N Engl J Med. 1992 Dec 17; 327(25):1815-6. View on Pubmed
  137. Kahn JG, Lurie P, Grumbach K. Consumer choices and the American health care system. JAMA. 1992 Sep 09; 268(10):1265-6. View on Pubmed
  138. Lurie P, Kahn JG, Wolfe SM. Regulation of benzodiazepine prescription. JAMA. 1992 Jul 22-29; 268(4):472-3; author reply 473-4. View on Pubmed
  139. Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA. 1991 Nov 13; 266(18):2594-604. View on Pubmed
  140. Peterson HB, Walker CK, Kahn JG, Washington AE, Eschenbach DA, Faro S. Pelvic inflammatory disease. Key treatment issues and options. JAMA. 1991 Nov 13; 266(18):2605-11. View on Pubmed
  141. Marx R, Aral SO, Rolfs RT, Sterk CE, Kahn JG. Crack, sex, and STD. Sex Transm Dis. 1991 Apr-Jun; 18(2):92-101. View on Pubmed